{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:50:11Z","timestamp":1790923811390,"version":"4.1.0"},"reference-count":71,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,1,21]],"date-time":"2011-01-21T00:00:00Z","timestamp":1295568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Punding (the display of stereotyped, repetitive behaviors) is a relatively recently discovered feature of Parkinson's disease (PD). Little is known about the prevalence and clinical characteristics of punding in PD.\n                    <jats:bold>Methods:<\/jats:bold>\n                    In this review, four large scientific databases were comprehensively searched for literature in relation to punding prevalence and clinical correlates in the context of PD.\n                    <jats:bold>Results:<\/jats:bold>\n                    Prevalence was found to vary greatly (between 0.34 to 14%), although there were large disparities in study populations, assessment methods, and criteria. We observed an association between punding, dopaminergic medications, and impulse control disorder. Other characteristics, which may be more common among punders, include a higher severity of dyskinesia, younger age of disease onset, longer disease duration, and male gender.\n                    <jats:bold>Discussion:<\/jats:bold>\n                    More research in large clinical datasets is required in many areas before conclusions are drawn. The pathophysiology behind the punding phenomenon is also poorly understood at present, rendering it difficult to develop targeted therapy. The current mainstay of treatment is the reduction in the dose of dopaminergic medications, the evidence for other suggested therapies being purely empirical. \u00a9 2011 Movement Disorder Society\n                  <\/jats:p>","DOI":"10.1002\/mds.23508","type":"journal-article","created":{"date-parts":[[2011,1,21]],"date-time":"2011-01-21T09:57:34Z","timestamp":1295603854000},"page":"578-586","source":"Crossref","is-referenced-by-count":76,"title":["The prevalence and clinical characteristics of punding in Parkinson's disease"],"prefix":"10.1002","volume":"26","author":[{"given":"Ashley H.","family":"Spencer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Rickards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea E.","family":"Cavanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900013778"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.8.1089"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.129015"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-007-5010-x"},{"key":"e_1_2_6_6_2","first-page":"203","article-title":"Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs","volume":"75","author":"Rylander G","year":"1972","journal-title":"Psychiatr Neurol Neurochir"},{"key":"e_1_2_6_7_2","first-page":"203","article-title":"Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs","volume":"75","author":"Rylander G","year":"1972","journal-title":"Psychiatr Neurol Neurochir"},{"key":"e_1_2_6_8_2","first-page":"509","article-title":"Cocaine\u2010induced psychosis","volume":"52","author":"Brady KT","year":"1991","journal-title":"J Clin Psychiatr"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.02.005"},{"key":"e_1_2_6_10_2","first-page":"81","article-title":"Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case\u2010control study","volume":"33","author":"Cornelius JR","year":"2010","journal-title":"Sleep"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22309"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1970.tb02939.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(94)90636-X"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5001-1"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3181684542"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/13554790802495324"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2006.04.019"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21202"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2007.04.004"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2006000600026"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2006.01.010"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20787"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20757"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2005.02.009"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.16947"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2003.08.002"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10625"},{"key":"e_1_2_6_28_2","first-page":"62","article-title":"Chronic dopaminergic drug addiction and pathologic gambling in patients with Parkinson's disease: presentation of four cases","volume":"5","author":"Serrano\u2010Duenas M","year":"2002","journal-title":"Ger J Psychiatr"},{"key":"e_1_2_6_29_2","first-page":"228","article-title":"Punding in Parkinson's disease","volume":"17","author":"Meseguer Gancedo E","year":"2002","journal-title":"Neurologia"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199909)14:5<836::AID-MDS1018>3.0.CO;2-0"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20045"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000238503.20816.13"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21296"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22678"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22571"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21118"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21702"},{"key":"e_1_2_6_38_2","first-page":"61","volume-title":"Violence and mental disorder developments in risk assessment","author":"Barratt ES","year":"1994"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/26.5.353"},{"key":"e_1_2_6_40_2","first-page":"S281","article-title":"Impulse control disorders in Parkinson's disease patients followed in a community\u2010based neurology practice","volume":"23","author":"Weiss HD","year":"2008","journal-title":"Mov Disord"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22505"},{"key":"e_1_2_6_42_2","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"e_1_2_6_43_2","article-title":"Preliminary evaluation of the DDS\u2010PC inventory: a new tool to assess impulsive\u2010compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease","author":"Cabrini S","journal-title":"Neurol Sci"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-5010-5"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000243252.71365.81"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2009.95"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.3_Part_1.505"},{"key":"e_1_2_6_48_2","first-page":"421","article-title":"Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease","volume":"2","author":"Kaasinen V","year":"2000","journal-title":"Curr Psychiatry Rep"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-000-0027-1"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.2.3.282"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.024885"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21454"},{"key":"e_1_2_6_53_2","volume-title":"Parkinson's Disease","author":"Kissoon N","year":"2009"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70411-2"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198804073181402"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3932(99)00103-7"},{"key":"e_1_2_6_57_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2005.03.024","article-title":"Dopaminergic modulation of cognitive function: implications for l\u2010dopa treatment in Parkinson's disease","volume":"30","author":"Cools R","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"key":"e_1_2_6_58_2","first-page":"701","article-title":"Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease","volume":"57","author":"Radad K","year":"2005","journal-title":"Pharmacol Rep"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.1_Suppl_1.S34"},{"key":"e_1_2_6_60_2","first-page":"401","article-title":"Behavior and mental activity disorders after carbon monoxide poisoning","volume":"140","author":"Ali\u2010Cherif A","year":"1984","journal-title":"Rev Neurol"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.47.4.377"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/112.3.699"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(00)00049-3"},{"key":"e_1_2_6_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(87)90144-0"},{"key":"e_1_2_6_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/73949"},{"key":"e_1_2_6_66_2","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1523\/JNEUROSCI.22-14-06218.2002","article-title":"Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioural phenotypes of cocaine sensitization","volume":"22","author":"Capper\u2010Loup C","year":"2002","journal-title":"J Neurosci"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(03)00065-1"},{"key":"e_1_2_6_68_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.16.7451"},{"key":"e_1_2_6_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20822"},{"key":"e_1_2_6_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2008.12.010"},{"key":"e_1_2_6_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20046"},{"key":"e_1_2_6_72_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23061"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.23508","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.23508","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.23508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:24:59Z","timestamp":1760952299000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.23508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,21]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1002\/mds.23508"],"URL":"https:\/\/doi.org\/10.1002\/mds.23508","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,21]]}}}